Court Rejects Merck’s Challenge to Medicare Drug Price Negotiation Program - Merck & Co (NYSE:MRK)

Merck, AZ lawsuits against Medicare price negotiations swatted down

Courts in Maryland and Washington, D.C., have rejected lawsuits by two pharma giants against the Centers for Medicare & Medicaid Services' (CMS) drug price negotiation program, introduced by fo | Courts in Maryland and…